Model for assessing the efficiency of biologic drugs in the treatment of moderate to severe psoriasis for one year in clinical practice in Spain.

Puig, L

Model for assessing the efficiency of biologic drugs in the treatment of moderate to severe psoriasis for one year in clinical practice in Spain. [electronic resource] - Actas dermo-sifiliograficas - 34-43 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1578-2190

10.1016/j.ad.2015.07.006 doi


Adalimumab--therapeutic use
Biological Products--economics
Decision Trees
Etanercept--therapeutic use
Humans
Infliximab--therapeutic use
Meta-Analysis as Topic
Psoriasis--drug therapy
Reproducibility of Results
Spain
Ustekinumab--therapeutic use